Journal of Clinical Endocrinology & Metabolism, Vol 64, 190-194, Copyright © 1987 by Endocrine Society

ARTICLES

Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man

BJ Wallum, GJ Taborsky Jr, D Porte Jr, DP Figlewicz, L Jacobson, JC Beard, WK Ward and D Dorsa

We hypothesized that plasma insulin crosses the blood-cerebrospinal fluid (CSF) barrier and, as people gain weight, provides a physiological feedback signal to the central nervous system to inhibit food intake and further weight gain. However, it has not been demonstrated in man that insulin can enter the CSF from peripheral blood. To test whether increases in plasma insulin result in elevated CSF immunoreactive insulin (IRI) levels, we infused insulin iv in varying amounts approximating postprandial levels in eight normal subjects for 4.5 h. Euglycemia was maintained [88 +/- 3 (+/- SEM) mg/dl] by means of a variable glucose infusion. Samples were obtained every 30 min for measurements of insulin in peripheral plasma and insulin in lumbar CSF. Plasma IRI increased from a mean basal level of 12 +/- 1.2 microU/ml to a mean (during the 180- to 270-minute period) of 268 +/- 35 microU/ml. CSF IRI increased in all subjects during the infusion from a mean basal level of 0.9 +/- 0.1 microU/ml to a mean (during the 180- to 270-min period) of 2.8 +/- 0.4 microU/ml (P less than 0.006). By contrast, CSF IRI in two subjects who received an infusion of 0.9% saline did not increase. In summary, CSF insulin concentrations increased during peripheral infusions of insulin. This is the first demonstration in man that plasma insulin gains access to CSF and indicates a mechanism whereby peripheral insulin could provide a feedback signal to the central nervous system.

This article has been cited by other articles:

				D. Cao, H. Lu, T. L. Lewis, and L. Li Intake of Sucrose-sweetened Water Induces Insulin Resistance and Exacerbates Memory Deficits and Amyloidosis in a Transgenic Mouse Model of Alzheimer Disease J. Biol. Chem., December 14, 2007; 282(50): 36275 - 36282. [Abstract] [Full Text] [PDF]

				M. Hallschmid, C. Benedict, B. Schultes, H.-L. Fehm, J. Born, and W. Kern Intranasal Insulin Reduces Body Fat in Men but not in Women Diabetes, November 1, 2004; 53(11): 3024 - 3029. [Abstract] [Full Text] [PDF]

				M. Hallschmid, B. Schultes, L. Marshall, M. Molle, W. Kern, J. Bredthauer, H. L. Fehm, and J. Born Transcortical Direct Current Potential Shift Reflects Immediate Signaling of Systemic Insulin to the Human Brain Diabetes, September 1, 2004; 53(9): 2202 - 2208. [Abstract] [Full Text] [PDF]

				B. E. Pulford and D. N. Ishii Uptake of Circulating Insulin-Like Growth Factors (IGFs) into Cerebrospinal Fluid Appears to Be Independent of the IGF Receptors as Well as IGF-Binding Proteins Endocrinology, January 1, 2001; 142(1): 213 - 220. [Abstract] [Full Text] [PDF]

				B. Bohrmann, L. Tjernberg, P. Kuner, S. Poli, B. Levet-Trafit, J. Naslund, G. Richards, W. Huber, H. Dobeli, and C. Nordstedt Endogenous Proteins Controlling Amyloid beta -Peptide Polymerization. POSSIBLE IMPLICATIONS FOR beta -AMYLOID FORMATION IN THE CENTRAL NERVOUS SYSTEM AND IN PERIPHERAL TISSUES J. Biol. Chem., June 4, 1999; 274(23): 15990 - 15995. [Abstract] [Full Text] [PDF]

				M. W Schwartz, D. G Baskin, K. J Kaiyala, and S. C Woods Model for the regulation of energy balance and adiposity by the central nervous system Am. J. Clinical Nutrition, April 1, 1999; 69(4): 584 - 596. [Abstract] [Full Text] [PDF]

				I. M. Chapman, E. A. Goble, G. A. Wittert, J. E. Morley, and M. Horowitz Effect of intravenous glucose and euglycemic insulin infusions on short-term appetite and food intake Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R596 - R603. [Abstract] [Full Text] [PDF]

				N. Takeshita and I. Yamaguchi Insulin Attenuates Formalin-Induced Nociceptive Response in Mice through a Mechanism that Is Deranged by Diabetes Mellitus J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 315 - 321. [Abstract] [Full Text]